
Diagnósticos da América S.A
DASA3 · SA · Healthcare / Diagnostics & Research
3.43BRL-0.20 (-5.51%)
Price History
Full chartMarket Stats
Previous Close3.63
Open3.61
Day Range3.43 – 3.74
52-Week Range1.28 – 4.77
Volume1.62M
Market Cap4.94B
P/E (TTM)0.00
Forward P/E40.98
EPS-0.71
Dividend Yield0.00%
Beta0.33
50-Day Avg2.83
200-Day Avg3.28
About
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. The company operates through Hospitals and Oncology; Diagnostics - National Operations; and Diagnostics - International Operations segments. It also offers medical, property and vehicle rental, consultancy, and franchise contracting services. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 2000. Diagnósticos da América S.A. was founded in 1961 and is headquartered in São Paulo, Brazil.
Company Details
- SectorHealthcare
- IndustryDiagnostics & Research
- CEOMr. Rafael Lucchesi
- Employees26.25K
- HeadquartersAv. das Nações Unidas, 7815, São Paulo, SP, Brazil, 05425-070, Brazil
- Websitehttps://www.dasa3.com.br
Leadership
- Mr. Rafael LucchesiChief Executive Officer
- Mr. Rafael BossolaniChief Financial & Investor Relations Officer
- Mr. Emerson Leandro GasparettoChief Radiology & Imaging Diagnosis Officer and Member of Management Board
- Ms. Paula Lígia de Oliveira DiasChief Legal Officer
- Mr. Helisson Brigido Andrade LemosVice President of Marketing and Products
- Mr. Alexandre Antonio Garcia Valente da SilvaVice President of Sales
- Mr. Fabio Sampaio De LacerdaVice President Director of People, Management & Culture
- Mr. Glauco DesiderioInvestor Relations Officer · b. 1976
- Mr. Andre CovreCorporate Strategy Officer · b. 1970
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap4.94B
Enterprise Value10.50B
Trailing P/E0.00
Forward P/E40.98
PEG Ratio0.64
Price / Sales0.53
Price / Book0.60
EPS-0.71
Book Value5.47
Revenue (TTM)9.32B
Gross Profit (TTM)2.89B
EBITDA1.48B
Profit Margin-9.60%
Operating Margin10.77%
Return on Equity-12.09%
Return on Assets3.53%
Shares Outstanding1.25B
Shares Float1.18B
Beta0.33
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%
Dividends
20221×
0.10Dec 26, 2022
20212×
0.30Dec 27, 20210.29Jan 12, 2021
20191×
0.56Dec 30, 2019
20183×
0.56Dec 28, 20180.14Apr 24, 20180.14Jan 1, 2018
20171×
0.00Apr 20, 2017
20162×
0.08Dec 29, 20160.02Apr 25, 2016
20151×
0.06Apr 23, 2015
20141×
0.10Apr 28, 2014
20131×
0.07Apr 22, 2013
20121×
0.03Apr 27, 2012
20111×
0.10Oct 3, 2011
20101×
0.13Dec 28, 2010
20091×
0.41Dec 10, 2009
20081×
0.23Mar 25, 2008
Stock Splits
- Feb 2, 20104:1